Podcast: This Week in Managed Care&amp;mdash;New Drug Pricing Probe and Other Health News

Reflecting on 15 Years of Health IT Evolution and What’s Next: Nate C. Apathy, PhD

These findings suggest the mental health burden in nonmelanoma skin cancer reflects broader social and clinical factors rather than disease-specific effects.

FAQ: What to Know About the Vaccine Rollbacks and What They Mean Long-Term

Nate C. Apathy, PhD, guest editor of AJMC's 15th Health IT special issue, calls for tools to be closely aligned with user needs.

Listen

Child receiving vaccine | Image credit: Nina Lawrenson/peopleimages.com - stock.adobe.com

Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD

With the CDC’s decision to roll back recommendations to vaccinate for several conditions, questions have arisen as to what that may mean in the US.

January 20th 2026

ctDNA Positivity Associated With Worse Survival, Higher Recurrence Risk in Patients With NSCLC

David Muhlestein, PhD, breaks down ghost rates, data gaps, and why stronger oversight is needed to make Transparency in Coverage files usable for patients.

Listen

Doctor conducting liquid biopsy | Image Credit: syhin_stas - stock.adobe.com

January 25th 2026

Socioeconomic Factors Linked to Surgical Outcomes in Upper Extremity Soft Tissue Sarcoma

These findings support the potential role of ctDNA in prognostic assessment and early intervention.

Socioeconomic and demographic factors were associated with variations in surgical outcomes among patients with upper extremity soft tissue sarcoma. | Image credit: @syahrir-adobestock.jpeg

January 22nd 2026

Mental Health Distress in Nonmelanoma Skin Cancer Largely Driven by Sociodemographic, Comorbid Factors

Socioeconomic and demographic factors influenced amputation and recurrence rates in upper extremity soft tissue sarcoma.

Related Content

January 31st 2026

Reflecting on 15 Years of Health IT Evolution and What’s Next: Nate C. Apathy, PhD

These findings suggest the mental health burden in nonmelanoma skin cancer reflects broader social and clinical factors rather than disease-specific effects.

FAQ: What to Know About the Vaccine Rollbacks and What They Mean Long-Term

Nate C. Apathy, PhD, guest editor of AJMC's 15th Health IT special issue, calls for tools to be closely aligned with user needs.

Listen

Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD

With the CDC’s decision to roll back recommendations to vaccinate for several conditions, questions have arisen as to what that may mean in the US.

January 20th 2026

ctDNA Positivity Associated With Worse Survival, Higher Recurrence Risk in Patients With NSCLC

David Muhlestein, PhD, breaks down ghost rates, data gaps, and why stronger oversight is needed to make Transparency in Coverage files usable for patients.

Listen

January 25th 2026

Socioeconomic Factors Linked to Surgical Outcomes in Upper Extremity Soft Tissue Sarcoma

These findings support the potential role of ctDNA in prognostic assessment and early intervention.

January 22nd 2026